Letter to the Editor

Posts about this type

PCC
Smartphone Applications: Therapy at Your Fingertips
Letter to the Editor

August 20, 2024

The authors discuss the advancements in smartphone applications for psychiatry, as well as some of the risks.
Vania Modesto-Lowe, Sofia Adams, Amanda Rossi
PCC
Zeroing in on Xylazine
Letter to the Editor

August 15, 2024

The authors discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.
Jasleen Kaur, Megan Nosol, Vania Modesto-Lowe
PCC
A Mnemonic for Psychiatric History of Presenting Illness
Letter to the Editor

July 18, 2024

In this letter to the editor, the author presents a mnemonic created to help clinicians obtain a psychiatric history.
Abdulsamad A. Aljeshi
PCC
Suicide Attempts in Gambling Disorder
Letter to the Editor

July 4, 2024

Drs Chamberlain and Grant investigate history of suicide attempts among treatment-seeking individuals with gambling disorder who participated in clinical trials in the US.
Samuel R. Chamberlain, Jon E. Grant
JCP
Mental Health Assessments for Fetal Interventions
Letter to the Editor

June 24, 2024

The authors offer guidance and raise awareness about the intersection of maternal mental health and fetal interventions.
Sindhura Vangala, Roy Williams Jr., Cara M. Buskmiller, et al
PCC
SSRI-Related Sexual Dysfunction
Letter to the Editor

June 20, 2024

The authors discuss 2 SSRI-related sexual dysfunction syndromes: post-SSRI sexual dysfunction and persistent genital arousal disorder.
Ahmed Naguy, Bibi Alamiri
PCC
Other Nonspecified Feeding or Eating Disorders: Pushing the Envelope
Letter to the Editor

June 18, 2024

The authors shed some light on a wide array of disturbed eating behaviors that defy current nosological and taxonomic boundaries and need further clarification.
Ahmed Naguy, Bibi Alamiri
JCP
Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?
Letter to the Editor

June 5, 2024

The authors discuss a study by Sawicki et al of dementia patients for whom 2.5 mg of THC was recommended for neuropsychiatric symptoms.
Marina Goldman, Dimitri Markov
JCP
THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov
Letter to the Editor

June 5, 2024

The authors reply to Goldman and Markov’s comments on their recent study of dispensary-obtained THC for dementia.
Erin K. Zahradnik, Cristian Hernandez
PCC
Intersection of ChatGPT and Reddit
Letter to the Editor

June 4, 2024

The authors discuss the interplay of online social media support groups and interactive chatbots, which may represent a new realm of mental health support.
Kripa Ahuja, Grace DeSena, David Spiegel
JCP
Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al
Letter to the Editor

May 27, 2024

Edward Silberman and colleagues respond to a letter about their recent commentary calling for benzodiazepine prescribing guidelines.
Edward Silberman, Antonio E. Nardi, Vladan Starcevic, et al
JCP
Psychiatric Disorders and Obstetric Complications
Letter to the Editor

May 27, 2024

Obstetric complications are associated with a higher prevalence of mood and anxiety disorders during the perinatal period.
Marine Jacquelin, Caroline Dubertret, Elodie Gaëlle Ngameni, et al
JCP
Evidence-Based Benzodiazepine Practice Guidelines Are Needed
Letter to the Editor

May 27, 2024

The authors discuss a recent commentary by Silberman et al recommending greater guidance in benzodiazepine prescribing.
Breanna Sigler, Bernard Silvernail, Alexis D. Ritvo, et al
PCC
An Initiative to Combat Addiction Stigma in Medical Education
Letter to the Editor

May 21, 2024

The authors describe the creation and implementation of a unique online module to address the stigma of addiction in a medical school curriculum.
Zoha Baig, Giselle Appel, Zoe Verzani, et al
PCC
What Clinicians Need to Know About Geriatric Depression
Letter to the Editor

May 16, 2024

The authors discuss what clinicians should be aware of when caring for elderly patients with depression.
Ahmed Naguy, Soliman Al-Khadhari
PCC
Potential Use of Antidepressants for Long COVID
Letter to the Editor

May 16, 2024

The possibility of repurposing antidepressants as a potential treatment for long COVID first emerged following observations that antidepressants might reduce morbidity and mortality when administered during acute COVID.
Rafael A. Rivas-Vazquez, Enrique J. Carrazana, Emma V. Rivas-Vazquez, et al
PCC
Fentanyl Test Strips and Drug Use Modification
Letter to the Editor

May 14, 2024

The authors explore the use of fentanyl test strips as a harm reduction tactic to identify contaminated substances for people who use illicit drugs.
Vania Modesto-Lowe, Robyn Roznitsky, Kiana Caitlin Tan
PCC
Do Not Overlook Bupropion Misuse
Letter to the Editor

April 30, 2024

Jasleen Kaur, MD, and colleagues comment on a case report published in the PCC.
Jasleen Kaur, Vania Modesto-Lowe, Roberto León-Barriera
JCP
Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?
Letter to the Editor

March 20, 2024

As choice of administration route is crucial during psychiatric emergencies, the authors stress the need for RCTs comparing onset of efficacy for agitation across different administration routes of the...
Xintong Mu, Hiroyoshi Takeuchi
PCC
Letter to the Editor

March 3, 2024

Notice of retraction for a letter to the editor.
PCC
Drug Interactions Between Psychotropic Medications and Mpox Treatment
Letter to the Editor

February 15, 2024

The authors review pharmacologic interactions of Mpox treatments with psychotropic medications and antidepressants, antipsychotics, mood stabilizers, and sedatives.
Zeeshan Mansuri, Bhumika Shah, Garima Yadav, et al
PCC
Intravenous Ketamine vs Intranasal Esketamine for TRD
Letter to the Editor

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.
Zeeshan Mansuri, Bhumika Shah, Garima Yadav, et al
PCC
Fentanyl-Laced Marijuana Use in Adolescents [Retracted]
Letter to the Editor

February 6, 2024

Sahar Ashraf, Kaushal Shah, Mohsin Ali, et al
JCP
Reckoning Risk Retrospectively: Reply to Taipale et al
Letter to the Editor

January 22, 2024

In a reply to Taipale and colleagues, Dr Andrade discusses estimation of risk in case-control studies and in RCTs.
Chittaranjan Andrade

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe